Skip to main content

News

News
12/09/2024
Machine learning techniques such as combining machine learning with echocardiography and electrocardiography (ECG), show promising results in diagnosing pulmonary arterial hypertension (PAH), offering a potential noninvasive alternative to...
Machine learning techniques such as combining machine learning with echocardiography and electrocardiography (ECG), show promising results in diagnosing pulmonary arterial hypertension (PAH), offering a potential noninvasive alternative to...
Machine learning techniques such...
12/09/2024
First Report Managed Care
News
12/09/2024
Developing a clinically meaningful immune-related adverse event (irAE) was associated with significantly improved overall survival in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) treated with immune...
Developing a clinically meaningful immune-related adverse event (irAE) was associated with significantly improved overall survival in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) treated with immune...
Developing a clinically...
12/09/2024
First Report Managed Care
News
12/04/2024
A recent consensus review discusses current management strategies for brain tumor-related epilepsy, with an emphasis on the role of antiseizure medications and surgical resection.
A recent consensus review discusses current management strategies for brain tumor-related epilepsy, with an emphasis on the role of antiseizure medications and surgical resection.
A recent consensus review...
12/04/2024
First Report Managed Care
News
12/03/2024
A machine learning algorithm predicted seizure control after temporal lobe resection using just 5 minutes of peri-ictal data from a scalp electroencephalogram (EEG) that is already part of the standard universal presurgical evaluation.
A machine learning algorithm predicted seizure control after temporal lobe resection using just 5 minutes of peri-ictal data from a scalp electroencephalogram (EEG) that is already part of the standard universal presurgical evaluation.
A machine learning algorithm...
12/03/2024
First Report Managed Care
News
12/03/2024
Asthma was associated with cognitive dysfunction in a sample of adults aged 60 years and older from the National Health and Nutrition Examination Survey (NHANES).
Asthma was associated with cognitive dysfunction in a sample of adults aged 60 years and older from the National Health and Nutrition Examination Survey (NHANES).
Asthma was associated with...
12/03/2024
First Report Managed Care
News
11/22/2024
New research highlights the potential of emicizumab, traditionally used to treat hemophilia A (HA), as a promising alternative therapy for certain hemophilia B (HB) genotypes.
New research highlights the potential of emicizumab, traditionally used to treat hemophilia A (HA), as a promising alternative therapy for certain hemophilia B (HB) genotypes.
New research highlights the...
11/22/2024
First Report Managed Care
News
11/22/2024
A recent study investigated the “sex paradox” in pulmonary arterial hypertension, which highlights better survival outcomes in women despite more severe disease presentation.
A recent study investigated the “sex paradox” in pulmonary arterial hypertension, which highlights better survival outcomes in women despite more severe disease presentation.
A recent study investigated the...
11/22/2024
First Report Managed Care
News
11/22/2024
Patisiran offers promising benefits for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare and fatal genetic disorder characterized by amyloid fibril deposits affecting multiple organs.
Patisiran offers promising benefits for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare and fatal genetic disorder characterized by amyloid fibril deposits affecting multiple organs.
Patisiran offers promising...
11/22/2024
First Report Managed Care
News
11/20/2024
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and...
11/20/2024
First Report Managed Care
News
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care